Independent. Trusted. Credible.

InGeNA

Industry collaboration for Australia’s genomics future

What's newGet involved

InGeNA

About

InGeNA is a single voice for Australian industry partners contributing to the rapidly developing field of genomics.

Alliance partners share a vision for Australia’s leadership in the adoption of genomics in healthcare.
– Better health outcomes
– Healthcare value and affordability
– A trusted, equitable and ethical genomics ecosystem

Collaboration across the key sectors of diagnostics/pathology, tech and pharma will ensure long and far-reaching benefits for Australian health consumers.

InGeNA the industry voice for the future of genomics in Australia

Webinar

The power of genomics: From patient to market

Tuesday 9 November | 12:00pm – 1:00pm AEDT | Online via Zoom

Join this webinar to hear from two expert speakers on unlocking the benefits and the immense potential of genomics in Australia, specifically around treating mental health and the implications for industry.

Regina Crameri presents the current genomics landscape in Australia, including government genomics initiatives, funding schemes and a case study on international collaboration. Ajeet Singh will then talk about the use of genomics to accurately predict the correct mental health treatment, and the value in shifting away from ‘trial-and-error’ processes to get it right the first time.

Who we are

InGeNA was formed by a group of industry organisations, hosted by the Australasian Institute of Digital Health (AIDH), to bring a shared perspective on critically important areas underpinning the future of genomics.

  • A patient-centred approach
  • Digital infrastructure & principles
  • Workforce planning & skills
  • Government policy making

VISION Realising the full potential of genomics to personalise healthcare

MISSION To harness the collective skills and expertise of industry to integrate genomics into healthcare

Stay connected, stay informed! We welcome your interest. Complete this form to sign up for regular news, events and updates.

Members

Members

Collaborative projects

 

This venture has received funding through the MTPConnect Project Fund Program – a dollar-for-dollar matched program investing in big, bold ideas to improve the productivity, competitiveness and innovative capacity of Australia’s medical technology, biotechnology and pharmaceutical sector. MTPConnect is supported by the Australian Government Industry Growth Centres Initiative – learn more at mtpconnect.org.au.

Partners

Partners

InGeNA is pleased to be formally working with the following Partners:

Chair’s Message

“We want Australians to have equity and access to the best that genomics can offer, now and in the future. With industry collaboration through InGeNA, there will be a single voice to have input into strategic planning, governance and funding directions through government, research centres and consumer health.”

David Bunker
InGeNA Chair

{

InGeNA News

Interview with the Chair David Bunker

Interview with the Chair David Bunker

InGeNA Chair David Bunker says in a few years genomics will be part of the normal healthcare system and a topic of broad social conversation. But he says while genomics has much to offer, it is advancing at such a pace, translation is struggling to keep...

read more
FACE it campaign!

FACE it campaign!

The first Childhood Dementia Day will be held on 22 September, organised by the Childhood Dementia Initiative. The Initiative also recently announced a newly appointed Scientific and Medical Advisory Committee. “It comprises 8 of Australia’s best and...

read more

Genomics technology

The promise of genomics is to help Australians live longer and healthier lives by integrating genomics into the management of health and integrating genomics information and workflows into the health system.

The current focus of genomics is on using individual genetic information to inform tailored healthcare decisions.

Genomics is also expected to have a large impact at the population level in the future. Genomics has the potential to enable earlier diagnosis, improve the identification of the best treatment for the patient, and assist in disease prevention by analysing many genes or the entire genome (comprising all 22,000 genes present in human DNA) at once.

 

COMING SOON

Contact Us

Office

Level 1, 85 Buckhurst Street,
South Melbourne VIC 3205, Australia